甲状腺乳头状癌复发:血清甲状腺球蛋白不可测时颈部超声的检出率低
该回顾性研究评估了甲状腺全切及放射性碘消融后甲状腺乳头状癌患者中,血清甲状腺球蛋白不可测(<0.1 ng/mL)时颈部超声的检出率。结果显示,76例血清甲状腺球蛋白不可测患者中18例超声提示复发可能,但均经细针穿刺或随访证实无复发;而65例血清甲状腺球蛋白升高患者中9例(34.6%)经细针穿刺证实复发,两组检出率差异有统计学意义(P = .001)。作者认为血清甲状腺球蛋白不可测时颈部超声未发现复发,取消该检查可减少不必要的影像检查。
要点
- 血清甲状腺球蛋白不可测(<0.1 ng/mL)时,颈部超声提示复发的18例患者均经细针穿刺或随访证实无复发。
- 血清甲状腺球蛋白升高时,颈部超声提示复发的22例中12例接受细针穿刺,9例(34.6%)证实甲状腺乳头状癌。
- 血清甲状腺球蛋白不可测时颈部超声检出率显著低于升高时(P = .001)。
核心结论
- 甲状腺全切及放射性碘治疗后,血清甲状腺球蛋白不可测(<0.1 ng/mL)的患者中颈部超声未识别出复发性甲状腺乳头状癌。
研究设计与样本
- 回顾性病历审查,2010年至2015年在一家学术机构进行,纳入甲状腺全切及放射性碘治疗后6个月内行颈部超声和血清甲状腺球蛋白检测的患者,复发参考标准为超声引导下细针穿刺病理结果或至少1年随访。
诊断标准与关键数值
- 血清甲状腺球蛋白不可测定义为<0.1 ng/mL。
- 76例血清甲状腺球蛋白不可测患者中18例(19次检查)超声提示复发可能,经细针穿刺(n = 8)或至少1年临床随访(n = 10)均无复发。
- 65例血清甲状腺球蛋白升高患者中22例(24次检查)超声提示复发可能,12例接受细针穿刺,9例(34.6%)证实甲状腺乳头状癌;7例随访颈部超声显示病灶稳定;3例失访。
- 血清甲状腺球蛋白不可测时颈部超声检出率显著低于升高时(P = .001)。
临床应用与阅片要点
- 作者认为,血清甲状腺球蛋白不可测时取消颈部超声可减少不必要的影像检查,且不影响复发检出能力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the yield of neck ultrasound (US) when serum thyroglobulin (Tg) is undetectable (<0.1 ng/mL) compared to elevated serum Tg in patients with differentiated papillary thyroid carcinoma (PTC) treated with thyroidectomy and radioactive iodine 131 (RAI) ablation.
METHODS: A retrospective chart review was conducted from 2010 through 2015 at an academic institution evaluating US results in patients with serum Tg levels obtained within 6 months of a neck US examination after thyroidectomy and RAI. The reference standard for recurrence was pathologic results from US-guided fine-needle aspiration (FNA) or follow-up for at least 1 year.
RESULTS: Among 76 patients with undetectable serum Tg levels, there were 19 examinations in 18 patients in which US raised the possibility of recurrence. None of these 18 patients had recurrence by FNA (n = 8) or clinical follow-up of at least 1 year (n = 10). Among 65 patients with elevated serum Tg levels, there were 24 examinations in 22 patients in which US raised the possibility of recurrence. Twelve patients underwent FNA, with 9 patients (34.6%) showing PTC; 7 patients had follow-up neck US examinations showing stability of findings; and 3 patients were lost to follow up. The yield of neck US was significantly lower when serum Tg was undetectable compared to when levels were elevated (P = .001).
CONCLUSIONS: Neck US did not identify recurrent PTC when the serum Tg level was undetectable in patients who underwent total thyroidectomy and RAI therapy. Eliminating neck US when serum TG levels are undetectable could decrease unnecessary imaging examinations without negatively affecting the ability to detect recurrent disease.
引用
- Epstein S, McEachern R, Khot R, et al. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level. J Ultrasound Med. 2018. PMID: 29498418. doi:10.1002/jum.14580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。